Modeling the Cost-effectiveness of HIV/AIDS Interventions in Different  Socio-economic Contexts in South Africa, (2007-2020) by Mbonigaba, Josue
ISSN 2039-2117 (online) 
ISSN 2039-9340 (print) 
        Mediterranean Journal of Social Sciences 
            MCSER Publishing, Rome-Italy 
Vol 4 No 3 
September 2013 
 
 587 
  
Modeling the Cost-effectiveness of HIV/AIDS Interventions in Different  
Socio-economic Contexts in South Africa, (2007-2020) 
  
Josue Mbonigaba1 
 
University of KwaZulu-Natal y 
E-mail: mbonigaba@ukzn.ac.za 
  
Doi:10.5901/mjss.2013.v4n3p587 
 
Abstract 
 
Evidence on how HIV/AIDS interventions compare on the basis of cost, effectiveness and cost-effectiveness estimates in 
different socio-economic contexts, has not been sufficient to guide policy-making in South Africa. To guide policy on how 
HIV/AIDS intervention resources should be allocated in rural and urban contexts, this paper aims to compare, over the period 
2007-2020, the cost-effectiveness of intervening in rural and urban contexts for each of the following HIV/AIDS interventions: 
prevention of mother-to-child transmission (PMTCT), highly active antiretroviral therapy (HAART) for adults and HAART for 
children.  Spectrum Policy Modeling System (SPMS) is used to project effectiveness over time and the number of annual 
patient-years using interventions in each context. The costs were derived from a systematic review of the available evidence 
and a scenario analysis was conducted.  The results show the dependence of the cost-effectiveness of HIV/AIDS interventions 
on the context of implementation and suggest the need for careful consideration, by South African policy makers, of the rural 
and urban contexts when allocating resources in HIV/AIDS interventions.  
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1. Introduction 
 
Despite a significant increase in resources committed to HIV/AIDS by the South African government since 2007 
(Govender, 2009), the impact of the epidemic remains high. Therefore, efficient ways of allocating resources to maximise 
health benefits are needed. With the evidence that the effectiveness (Grassly, Garnett, Schwartlander, Gregson & 
Anderson., 2001; Wegbreit, Bertozzi, DeMaria & Padian, 2006) and, by implication, the cost of HIV/AIDS interventions 
depend on socio-economic contexts, the on-going question remains: Does the cost and effectiveness of an HIV/AIDS 
intervention in South Africa depend on whether the intervention is implemented in a rural area/context or an urban 
area/context? For if such dependence exists, South African policy makers would allocate resources to HIV/AIDS 
interventions according to how t they are efficient in rural and urban contexts. This allocation, however, implies that the 
policy makers are aware of how cost-effectiveness estimates of several HIV/AIDS interventions compare in a rural 
context and an urban context, but this evidence has not been sufficiently produced in South Africa.  Therefore, this paper 
aims to provide such estimates, through modeling.  
An increased commitment of resources in the response to HIV/AIDS in South Africa followed a serious 
commitment to dealing with the epidemic by the South African government since 2007, after many years of controversial 
responses (Chigwedere, Seage, Gruskin, Lee & Essex, 2008; Fassin & Schneider, 2003; Johnson, 2004). In 2009, for 
example, the Zuma administration committed itself to the implementation of the five-year (2007-2011) National Strategic 
Plan (NSP), which focused on prevention and treatment. On World AIDS Day in 2009, President Zuma announced that,  
by April 2010,  all children under one year who test HIV-positive would get ARV treatment, and that all pregnant women 
and patients with TB would receive ARV drugs if their CD4 count fell below 350 (Govender, 2009). In the same year, he 
launched an HIV counseling and testing (HCT) campaign with a target of 15 million (about one third of the population), by 
June 2010 (Cullinan & Bodibe, 2010). By the time of this announcement, about seven million people were testing for HIV 
annually and 923 000 were receiving treatment (Department of Health, 2010:15). In 2011, the government adopted early 
treatment policies which consisted of starting the provision of HAART therapy on patients when their CD4 count reached 
a threshold of 350. Implemented officially in April 2013 (Department of Health, 2013), this policy replaced the late 
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treatment policy according to which patients started antiretroviral therapy (ART) when their CD4 count reached a 
threshold of 200. In the same year, universal coverage for adult patients was adopted. This consisted of providing 
HAART therapy to any patient who needs it according to the early treatment guidelines. On AIDS Day in December 2012, 
the deputy president of the country announced that about 1.9 million patients were on antiretrovirals (Xinhua, 2012). On 
the resources front, the HIV/AIDS budget in 2010 increased by 33% over the previous year, and in 2011, it increased 
further by 30% (Motsoaledi, 2011). 
These commitments have started paying off in terms of the reduction of the impact of HIV/AIDS. For instance, 
some studies have reported that survival among HIV/AIDS patients increased following the speed of scaling up 
antiretroviral therapy (Walensky et al., 2008). Other evidence revealed a decrease in secondary infections as result of the 
widespread rollout of antiretroviral drugs, which decreased viral loads in the infected population (Williams, Lima & Gouws, 
2011, Department of Health 2011:25). The rate of transmission from mother-to-child decreased from 8% in 2008 to 2.7% 
(Leach-Lemens, 2011). Furthermore, life expectancy increased from 56 years in 2008 to 60 years in 2011 (Xinhua, 2012). 
These benefits are not only limited to health outcomes but to broader socio-economic benefits given the link between 
health status and socio-economic life.  
Though South Africa has recently seen a decrease in the impact of HIV/AIDS, the scale of the epidemic remains 
significant. The significance of the epidemic can be highlighted by reporting the most recent statistics. In 2012, for 
example, there were about 220,000 AIDS-related deaths and 110,000 new infections, while 5,685,424 people were living 
with HIV or AIDS (Actuarial Society of South Africa, 2011). The importance of the epidemic implies that available 
resources are managed efficiently in order to achieve the maximum health benefits possible from available resources. 
One way to manage efficiently these resources is to allocate them in HIV/AIDS interventions in rural and urban contexts 
according to how these interventions are most efficient in these contexts.  
The allocation of resources in an HIV/AIDS intervention in a rural or an urban context based on the efficiency of 
such an intervention in each context requires, however, an estimation of the cost-effectiveness of that intervention to 
guide resources allocation. The cost-effectiveness of an HIV/AIDS intervention in a rural or an urban context is, however, 
uncertain and consequently the extent of the difference in the cost-effectiveness of a given intervention across a rural and 
an urban context is unknown. This is because such cost-effectiveness is a result of the interaction between the 
intervention and the context in which it is implemented.  The uncertainty of cost-effectiveness in a given context starts 
with uncertainty regarding the impact of HIV/AIDS in that context, which leads to  uncertainty concerning the 
effectiveness of an HIV/AIIDS intervention, that is, the reduction of the impact by the intervention in that context. The 
uncertainty regarding effectiveness leads in turn to uncertainty regarding costs of an intervention in a specific context.   
The theory of the socio-economic determinants of health proposes that the impact of HIV/AIDS is lower in a 
context with higher socio-economic status (Marmot & Wilkinson, 2005), for example, an urban context. This statement is 
based on the factors prevailing in a higher socio-economic status, such as, high levels of income and education, which 
are conducive to favorable health conditions and the avoidance of risky behaviours. This prediction of the theory of socio-
economic determinants of health implies that the impact of HIV/AIDS is higher in a rural context than in an urban context.  
Further implications of the theory are that the effectiveness of an HIV/AIDS intervention is lower in a rural context than it 
is in an urban context, based on the understanding that the effectiveness of an HIV/AIDS intervention is measured 
according to the extent to which it reduces the impact of HIV/AIDS. The lower effectiveness of an HIV/AIDS intervention 
in a rural context is due to the fact that an HIV/AIDS intervention does not have an effect on all factors which are 
responsible for the difference in the impact in a rural or an urban context.  
The difference in the impact of HIV/AIDS across a rural context and an urban context, as a result of interaction 
between the intervention and the context, implies also a difference in costs.  The difference in the cost of an intervention 
in rural and urban contexts can be grasped through the realization that an HIV/AIDS intervention earmarks specific 
activities related to the impact. For example, specific procedures are earmarked for patients whose CD4 count has 
reached a critical stage, while specific procedures are planned for patients with mild conditions. Since these HIV/AIDS 
impacts are caused by or originate from contextual factors, they prevail to a different extent in the rural context and an 
urban context. Consequently, since these health impacts influence the activities of an HIV/AIDS intervention, and since 
they may prevail to a different extent in a rural and an urban context, they may lead to differences in the cost of an 
HIV/AIDS intervention in these two contexts. According to the theory of the socio-economic determinants of health, a rural 
context is expected to be more impacted by the consequences of HIV/AIDS, such as new infections, AIDS sicknesses 
and AIDS-related deaths, than does an urban context.  
It is to be noted, however, that the prediction of the theory of socio-economic determinants of health may not be 
always valid. In fact, the theory prediction is founded on the assumption that contextual factors influence average 
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individual behaviours and attitudes towards HIV/AIDS intervention in a similar manner. Other theories, however, indicate 
that there are individual-specific factors which guide risky behaviours and attitudes towards interventions. Psychosocial 
theories, for example, explain that risk behaviours or attitudes towards HIV interventions depend on the ability and 
willingness to learn about change in such behaviours or attitudes (Rosenstock, 1974; Fishbein & Ajzen, 1975; Ajzen 
1991). Economic theory explains that unsafe risk behaviour (sexual behaviour/attitude towards health interventions) is 
based on a cost and utility analysis between sexual partners, or a cost and utility analysis of patients with respect to using 
a specific HIV/AIDS intervention (Becker 1976; Phillipson & Posner, 1993; Levy, 2002; Oster, 2007; Bhattacharya, 
Bunzel, & Qiao, 2007). Epidemiological theories focus less on individual behaviours, but on epidemic behaviour, thus 
highlighting the fact that the risk of infections and the effectiveness of interventions depend largely on HIV prevalence 
within particular contexts (Geoffard & Phillipson, 1996). All these individual factors may prevail to a different extent in a 
rural context and an urban context, and may reverse the pattern predicted by the theory of the socio-economic 
determinants of health. For instance, a rural context may comprise people who predominantly adopt safe sexual 
behaviour because of individual respect for the norms in this context.  
These theories imply that the way in which a rural and an urban context influence the cost-effectiveness of an 
intervention, is a result of interaction between the intervention and these theoretical factors in each context. Since the 
extent to which these theoretical factors prevail in a rural context and an urban context is uncertain and different; the 
extent to which they influence the impact of HIV/AIDS, the effectiveness and the cost of an HIV/AIDS intervention in a 
rural and an urban context, is also uncertain and different. This difference in the cost and effectiveness of an HIV/AIDS 
intervention in rural and urban contexts implies potential efficiency opportunities since the policy makers would allocate 
more resources to an intervention in a context where such an HIV/AIDS intervention results in a lower cost per health 
outcome, to increase efficiency.  
Despite the potential to achieve efficiency by allocating resources in a rural context or an urban context according 
to the cost-effectiveness of an HIV/AIDS intervention in a specific context, this cost-effectiveness has not been estimated 
for major HIV/AIDS interventions in South Africa. The estimation of the cost-effectiveness of an HIV/AIDS intervention in 
a rural and an urban context would require a follow-up of patients in each context, which is costly, and can only provide 
cost-effectiveness estimates up to the point of follow-up while policy makers need to plan for the future. Consequently, 
this  paper  models the cost-effectiveness and compares such cost-effectiveness across a rural context and an urban 
context for major HIV/AIDS interventions in South Africa, notably prevention of mother-to-child transmission (PMTCT), 
HAART for adults and HAART for children, with a view to advising the policy maker on how to allocate resources in these 
contexts to increase efficiency. 
 
2. Methods 
 
In each context, the incremental cost-effectiveness ratio (ICER) of an HIV/AIDS intervention relative to usual care is 
calculated.  The ICER of an HIV/AIDS intervention relative to usual care in a rural context is then compared to its ICER 
relative to usual care in an urban context.  
The total costs and total health outcomes of an HIV/AIDs intervention and usual care in each of these contexts 
form the basis of the calculation of the ICER, which, in relation to usual care, is defined as the ratio of incremental costs 
to incremental effectiveness of an HIV/AIDS intervention. The total costs of an HIV/AIDS intervention in a context is the 
sum of the annual costs over the period 2007-2020, obtained by multiplying the annual number of patients by the average 
annual cost. It is assumed that in the absence of an HIV/AIDS intervention, patients in an HIV/AIDS intervention use 
usual care. Consequently, the total cost of usual care in a context is obtained by multiplying the annual average cost of 
usual care by the annual number of patients using an HIV/AIDS intervention. Total health outcomes of an HIV/AIDS 
intervention is the sum of annual health outcomes over the period 2007-2020 while total health outcomes of usual care 
are the sum of annual health outcomes over the period 2007-2020.  
The incremental costs of an HIV/AIDS intervention over the period 2007-2020 is calculated as the difference 
between the total cost of an intervention and the total costs of usual care. The incremental effectiveness is calculated as 
the total health outcomes (number of HIV infections, deaths) of usual care minus the total health outcomes of HIV/AIDS 
interventions. Because the total number of infections and deaths are higher in the case of usual care than in the case of 
an intervention, the incremental effectiveness of an HIV/AIDS intervention consists of infections and deaths averted. The 
incremental costs and incremental effectiveness is used to calculate the ICER.  
The annual number of patients in a rural context and in an urban context over the period 2007-2020 and the annual 
number of health outcomes are projected by Spectrum Policy Modeling System (SPMS) of the Futures Group 
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International (Stover, 2004; 2009). The SPMS is a modular programme which integrates many models from which 
researchers can activate those relevant to their research questions. The SPMS has been extensively used to inform 
policy on many aspects at national levels (Rehle & Shisana, 2003; Wood et al., 2000) or sub-national level (Mekonnen, 
Jegou, R., Continho, R.A., Nokes, J. & Fontanet., 2002). One of the model’s most recent uses was the estimation of the 
impact of expanded access to antiretroviral therapy in ten sub-Saharan countries, including South Africa (Anema et al., 
2011). The SPMS is updated every two years to take account of the changes in the sector of HIV/AIDS (Stover, Walker, 
Grassly & Marston, 2006). In this paper, the estimation of the cost-effectiveness required an activation of the population 
model, AIDS impact model and intervention model of SPMS. Though the model is prepopulated with South African input, 
it does not include inputs relevant to a rural or an urban context.  So these input parameters had to be used in the three 
models.  
For the population model, default United Nations (UN) Population Division model parameters for South Africa were 
adjusted to reflect the realities in the rural context and urban context in South Africa. The paper used population per age 
and gender for the base year, 1981, for the projection. The year was chosen as the base year for the demographic 
projection on the recommendation of the model builders  to start projection two years before the first case of AIDS in the 
country, observed in 1983 (Abdool Karim & Baxter, 2010:39). Life expectancy assumption was based on the UN 
Population Division statistics.  With regard to age distribution of fertility, that is, how age groups share the number of 
births over time, it was assumed that a greater proportion of births from the young group occurred in the urban context 
relative to rural context, following a tendency of younger females to move to urban areas. Life expectancy was assumed 
to be higher among females than males (Statistics South Africa, 2010), but no differences were assumed concerning 
patterns of life expectancy across rural contexts and urban contexts over time, given  the absence of evidence in this 
respect and given the evidence that HIV has been more prevalent in the urban population (Shisana & Rehle, 2002). The 
total fertility rate in each area – the average number of children born to a woman in her lifetime –was also set at the South 
African total fertility rate due to the absence of data for the rural context and the urban context.  
For the AIDS impact model, the study modeled prevalence in a rural and an urban context because the impact of 
HIV/AIDS has not been routinely reported in both contexts in South Africa. One study which reported the impact of 
HIV/AIDS in rural and urban areas was that of the HSRC (2002), which showed that the prevalence of HIV/AIDS was 
greater in urban areas than in rural areas. In this study, the urban areas comprised urban informal (townships) and urban 
formal (metropolitan) areas, while rural areas had two categories, tribal areas and farm areas. The present research 
combined urban informal and urban formal to comprise urban areas, and tribal and farm areas to comprise rural areas, 
and recalculated the prevalence of HIV in urban and rural areas based on the sample weights in each sub-area, and 
greater HIV prevalence in urban areas was used (HSRC/MRC/CADRE, 2002; 2005 & 2008). The available evidence on 
prevalence in each area was used in the Estimation and Projection Package (EPP) to estimate annual infections in each 
context following procedures in other studies (see Rehle and Shisana (2003), for instance).  
For the intervention model, the effectiveness evidence for HIV/AIDS interventions was used. In the absence of 
PMTCT data, the model assumed an infection rate of 30% in the rural context and of 28% in the urban context, based on 
the evidence regarding PMTCT in developing countries and differences in risk in rural and urban contexts (Decock et al., 
2000; Department of Health, 2003). Following recent evidence, the infection rate under PMTCT interventions was 
assumed to be 5% in the urban context and adjusted to 6% in the rural context. For HAART interventions, the median 
time from infection to death was set at 10.5 years for adults in the urban context and to 9 years in the rural context. The 
median time from eligibility for treatment (at CD4 count 350) to death was assumed to be to be 7.9 years for adults in the 
urban context and 6.7 for adults in the rural context. The annual survival on ART was assumed to be 90% and 85% for 
adults in an urban and rural context, respectively, and 85% and 80% for children in an urban and rural context, 
respectively (UNAIDS 2009). Table 1 below provides a summary of the key demographic, AIDS impact, and intervention 
parameters used in the projections.  
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Table 1. Key input parameters in the model  
 
Rural  context
Baseline parameter Base-case Value Source 
Total population in 1981
Life expectancy at birth  in 1981 
Male 
Female 
Net migration 
Perinatal transmission among breastfeeding women 
with no intervention 
Median time from HIV infection to death (no intervention 
 
Prevalence rate (general population) 
Net migration 
14,500,000
 
55.1 
61.7 
9776 
30% 
 
9 years 
 
8.3% 
9776 
UN population division 
 
UN population division 
UN population division 
UN population division 
Decock et al .(2000) 
 
Assumption ( based  on UNAIDS and  
Department of Health, 2003) 
Based on Shisana & Simbayi (2002) 
Statistics South Africa (2010) 
Urban context
Total population in 1981
Baseline life expectancy at birth  in 1981 
Male 
Female 
Net migration 
Perinatal transmission among breastfeeding women  
(no intervention  ) 
Median time from infection to AIDS or deaths death (no 
intervention) 
HIV prevalence rate(general population) 
15,200,000
 
55.1 
61.7 
11283 
28% 
 
10.9 
 
13.3 
UN population division 
 
UN population division 
UN population division 
Statistics South Africa (2010) 
Assumption (Based on the Department of 
Health 2003) 
UNAIDS (2009) 
 
Based on Shisana & Simbayi (2002) 
 
As would be expected, a high level of uncertainty is likely in this kind of modeling and as a result, before using the model 
projections for CE estimates in a rural context and an urban context, calibration is done. Specifically, the paper compares 
the sum of population data modeled by the paper in a rural context and in an urban context, to the South African 
population data modeled by ASSA2008 AIDS model (Actuarial Society of South Africa, 2011). The paper compares also 
the sum of HIV prevalence data modeled by the paper in a rural context and in an urban context, to the South African 
prevalence data modeled by ASSA2008 AIDS model (Actuarial Society of South Africa, 2011). Data modeled by this 
paper compares favorably with data modeled by ASSA2008 AIDS models as shown in Figure 1 and therefore can be 
used to model cost-effectiveness.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Comparison of modeled data to population data and prevalence  
 
Given that not everyone accepts or adheres to treatment, the model assumes a coverage rate of 97% in each 
area, regardless of the intervention. The average annual costs per patient in each area is determined via a systematic 
review of the available evidence of the costs of modeled interventions, and the incremental cost-effectiveness ratios 
(ICER) of each intervention over usual care is estimated. The ICERs of an intervention is compared across a rural context 
and an urban context. All costs are estimated in 2007 constant US$ to control for inflation. The time preference is taken 
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into account by applying a 3% discount rate as per recommendation by an expert panel on cost-effectiveness analysis 
(Gold, Siegel, Russell,   Weinstein, 1996).  
The baseline comparison is carried out using the parameters listed, the coverage rate of 97%, the discount rate of 
3%, and the average annual cost of the base-case analysis. However, given the uncertainty underlying estimates, 
alternative discount rates of 0% and 7% are also used (Gold et al., 1996).  With widespread antiretroviral therapy, 
patients’ adherence to treatment is expected to drop based on the evidence of the increase in risky behaviours in 
developed countries arising from HAART-induced improvement in health status (McGowan et al., 2004). Since a drop in 
the adherence would affect the coverage rate of the interventions, scenario analyses of how the base-case conclusion 
changes when interventions coverage decrease to 80% in the rural areas or in the urban areas are conducted. In the first 
place, the changes in the base-case scenario were analyzed with assumptions of an 80% coverage rate in the rural 
areas, and then an 80% coverage rate in the urban areas. Finally, scenario analysis is conducted over the base-case 
scenario by using lower- and upper-bound estimates of costs in keeping with high variability and insufficiency in cost-
estimates evidence.  
 
3. Results   
 
3.1 Incremental costs  
 
The cost results are presented in Table 2. These costs are obtained by applying the average annual cost per patient to 
the number of patient-years using interventions over the period of analysis, as projected by SPMS.   
 
Table 2 Comparisons of incremental costs of HIV/AIDS interventions in socio-economic contexts (2007-2020) in US$ 
 
                                                                                      Rural context
intervention PMTCT HAART  FOR 
ADULTS  
HAART FOR 
CHILDREN  
Total cost USUAL CARE GP
Total cost USUAL CARE SP 
Total cost of intervention GP 
Total cost of intervention SP 
Incremental costs  GP 
Incremental costs  SP 
Incremental costs per 100,000 patient-years 
(GP) 
Incremental costs per 100,000 patient-years 
(SP) 
162,570,017
177,349,110 
322,328,839 
347,506,006 
159,755,822 
170,156,896 
 
10,580,584 
 
11,269,445 
892,784,873
982,063,361 
2,193,204,948 
2,312,134,705 
1,300,420,075 
1,330,071,344 
 
16,872,721 
 
19,277,221 
105,911,427 
116,502,569 
364,473,357 
379,172,279 
258,561,930 
262,669,710 
 
13,221,339 
 
13,431,387 
                                                                                 Urban context
Total cost USUAL CARE GP
Total cost USUAL CARE SP 
Total cost of intervention GP 
Total cost of intervention SP 
Incremental costs of intervention  GP 
Incremental costs  of intervention SP 
Incremental cost per 100,000 patient-years  
GP 
Incremental cost per 100,000 patient-years  
GP 
73,895,462
88,674,555 
466,791,038 
510,737,895 
392,895,576 
422,063,340 
 
18,041,585 
 
19,380,956 
3,190,138,899
3,312,836,549 
5,673,879,395 
6,086,733,645 
2,483,740,496 
2,773,897,096 
 
12,257,920 
 
13,689,920 
155,043,316 
212,427,251 
534,691,666 
606,564,596 
379,648,350 
394,137,345 
 
12,730,501 
 
13, 216,351 
IC per 100,000 patients  GP rural /IC per 
100,000 patients  GP *100 
58% 137% 103%
 
Source: Author, based on the results of SPMS projections. GP:  government perspective; SP: societal perspective.  
 
As Table 2 shows, the total costs of interventions are less in a rural context than they are in an urban context, and the 
incremental costs are also less in a rural context than they are in an urban context.  Based on the government 
perspective’s costs for example, Table 2 shows that HAART FOR ADULTS results in incremental costs of US$ 
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1,300,420,075 in a rural context while the corresponding number for an urban context is US$ 2,483,740,496. These 
results are obvious given that an urban context, as defined in this paper, has a greater number of people living with 
HIV/AIDS. The comparison is more plausible if the difference in the population of patients across a rural context and an 
urban context is controlled for. Doing such a control by estimating the incremental costs per 100, 0000 patient-years, and 
Table 2 shows that per 100,000 patient-years, the incremental costs are generally higher in rural contexts, except for 
PMTCT. The incremental cost per 100,000 patient-years for PMTCT is US$ 10,580,584 in a rural context while it is 
US$18,041,585 in an urban context, considering costs evaluated from the perspective of government. The last row of 
Table 2 shows the incremental costs in a rural context expressed as a percentage of the incremental costs in an urban 
context for each intervention. The row indicates that this percentage is 58% for PMTCT while it is 137% and 103% for 
HAART FOR ADULTS and HAART FOR CHILDREN. 
 
3.2 Incremental effectiveness  
 
After comparing the incremental costs of each HIV/AIDS intervention relative to usual care across a rural context and an 
urban context, it is worth also comparing the incremental effectiveness of an HIV/AIDS intervention in a rural context and 
in an urban context. The effectiveness measures used in this comparison are infections and deaths averted by an 
HIV/AIDS intervention relative to usual care. Table 3 shows the results.  
 
Table 3 Comparison of incremental effectiveness of HIV/AIDS interventions in socio-economic contexts (2007-2020)  
 
Intervention EffectivenessRural context Urban context 
No intervention at all
Cumulative paediatric  infections 
Cumulative adult deaths 
Cumulative paediatric deaths 
315,258 
2,119,490 
222,628 
505,661 
3,528,417 
353,781 
PMTCT 
Total infections with PMTCT 
Paediatric infections averted by PMTCT 
HAART FOR ADULTS 
Total adult deaths with HAART FOR ADULTS 
Total adult  deaths averted by HAART ADULTS 
HAART FOR CHILDREN 
Total child deaths with HAART FOR CHILDREN 
Total child  deaths averted by HAART FOR CHILDREN 
198,392 
116,866 
 
1,590,003 
529,487 
 
108,523 
114,105 
314,987 
193,164 
 
2,077,634 
1,450,783 
 
170,376 
183,405 
 
Source: Author, based on the results of SPMS projections.   
 
The results in Table 3 indicate  that for each HIV/AIDS intervention, the number of infections (deaths) averted by an 
HIV/AIDS intervention relative to USUAL CARE is less  in a rural context than it is in an urban  context. For instance, 
PMTCT averts 116,866 infections over the period 2007-2020 in a rural context and 193,164 infections in an urban context 
over the same period. However, this finding needs to be considered bearing in mind that the size of the population of 
patients in these contexts is different. Since there are fewer patients in an HIV/AIDS intervention in a rural context, fewer 
infections and deaths averted are expected there. To control for the number of patients as in the analysis of incremental 
costs, estimates of incremental effectiveness are reported per 100,000 patient-years in each context. Table 4 shows the 
results.    
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Table 4 Comparison of incremental effectiveness of HIV/AIDS Interventions in socio-economic contexts per 100,000 
patient-years (2007-2020)  
 
HIV outcomes Rural contextPMTCT HAARTA HAARTC 
A1. Total patient-years
B1. Total infections averted 
C1. Averted infections per 100,000 patient-years 
 
A1. Total patient-years 
B1. Total adult deaths averted by HAARTA 
C1. Averted infections per 100,000 patient-years 
A1. Total patient-years 
B1. Total child deaths averted by HAARTC 
C1. Averted infections per 100,000 children-years 
893,972
116,866 
77,400 
 
 
 
 
 
 
5,693,664 
529,487 
68,700 
 
 
 
 
 
 
 
 
663,813 
108,523 
58,500 
HIV outcomes Urban contextPMTCT HAARTA HAARTC 
A2. Total patient-years
B2. Total infections averted 
C2. Averted infections per 100,000 patient-years 
 
A2. Total patient-years 
B2. Total adult deaths averted by HAART 
C2. Averted infections per 100,000 patient-years 
 
A2. Total patient-years 
B2.Total child deaths averted by HAART 
C2. Averted infections per 100,000 children-years 
1,472,686
190,674 
88,700 
 
 
 
 
 
 
 
 
15,649,025 
1,450,783 
71,600 
 
 
 
 
 
 
 
 
 
987,837 
183,405 
61,500 
C1/C2*100 91% 65% 80% 
 
Source: Author, based from SPMS projections.  
 
As Table 4 indicates, modeled HIV/AIDS interventions are less effective in a rural context than they are in an urban 
context. Table 4 indicates that per 100,000 patient-years, PMTCT prevents less HIV infections in a rural context than it 
does in an urban context. In fact, the intervention prevents 7, 7400 infections in a rural context while it prevents 88,700 
infections in an urban context over the period of analysis. Similarly, HAART FOR ADULTS and HAART FOR CHILDREN 
prevent fewer deaths in a rural context. Per 100,000 patient-years, HAART for ADULTS prevents 68,700 HIV/AIDS 
deaths in a rural context while it prevents about 71,600 HIV/AIDS deaths in an urban context. Corresponding statistics of 
HIV/AIDS deaths averted by HAART FOR CHILDREN are 58,500 (rural) and 61,500. Because less HIV infections and 
HIV/AIDS deaths are averted in a rural context, the incremental effectiveness in a rural context expressed as percentage 
of the incremental effectiveness in an urban context is less than 100%.  
 
3.3 Cost-effectiveness   
 
In a cost-effectiveness analysis, however, it is important to analyse the additional costs arising from additional benefits, 
relative to usual care, of an HIV/AIDS intervention in each context. The ICER of an HIV/AIDS intervention relative to 
“usual care” is reported in a rural context and an urban context and the ICERs of the same intervention are compared 
across these two contexts, in the base–case comparison.  Table 5 shows the results. 
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Table 5. Comparisons of ICERs of HIV/AIDS interventions in socio-economic contexts (2007-2020), base-case value    
 
                                                Rural context 
Description  PMTCT HAART FOR 
ADULTS  
HAART FOR 
CHILDREN  
Total cost USUAL CARE GP
Total cost USUAL CARE  SP 
Total cost of intervention  GP 
Total cost of intervention   SP 
Incremental cost of intervention  GP 
Incremental cost of intervention  SP 
ICER GP 
ICER SP 
162,570,017
177,349,110 
322,328,839 
347,506,006 
159,755,822 
170,156,896 
1,367 
1,538 
892,784,873
982,063,361 
2,193,204,948 
2,312,134,705 
1,300,420,075 
1,330,071,344 
2,456 
2,806 
105,911,916 
116,502,569 
364,473,357 
379,172,279 
258,561,930 
262,669,710 
2,266 
2,379 
                                                 Urban context
Total cost USUAL CARE GP
Total cost USUAL CARE SP 
Total cost of intervention  GP 
Total cost of intervention  SP 
Incremental cost of intervention  GP 
Incremental cost of intervention  SP 
ICER GP 
ICER SP 
ICER rural GP/ICER urban GP*100 
73,895,462
88,674,555 
466,791,038 
510,737,895 
392,895,576 
422,063,340 
2,034 
2,051 
67% 
 
3,190,138,899
3,312,836,549 
5,673,879,395 
6,086,733,645 
2,483,740,496 
2,773,897,096 
1,712 
1,912 
143% 
155,043,316 
212,427,251 
534,691,666 
606,564,596 
379,648,350 
394,137,345 
2,070 
2,149 
109% 
 
Source: Author, based on the results of SPMS projections.  GP: government perspective, SP: societal perspective. The 
percentage in the last row Table 5 reflects the value of the ICER in a rural context as percentage of the ICER in an urban 
context for a given HIV/AIDS intervention.  
 
The results in Table 5 indicate that PMTCT is more cost-effective in a rural context than it is in an urban context. From a 
government perspective’s costs, the ICER of PMTCT in a rural context is US$1,367 per infection averted in a rural 
context while it is US$2,034 in an urban context.  In terms of relative cost-effectiveness, the ICER of PMTCT in a rural 
context is 67% of its ICER in an urban context. Therefore, PMTCT is more cost-effective in a rural context than it is in an 
urban context. 
HAART FOR ADULTS and HAART FOR CHILDREN are less cost-effective in a rural context than they are in an 
urban context. Their ICERs are US$ 2,456 and US$ 2,266 respectively per death averted in a rural context while these 
ICERs are US$1,712 and US$2,070 per death averted in an urban context. In terms of relative cost-effectiveness, the 
ICERs of HAART FOR ADULTS and HAART FOR CHILDREN in a rural context are 143% and 109% of their respective 
ICERs in an urban context. This result shows that HAART FOR ADULTS and HAART FOR CHILDREN are relatively less 
cost-effective in a rural context.  
Furthermore, the results in Table 5 show the extent to which CE estimates vary across HIV/AIDS interventions. 
The extent of CE in any context is measured by how far the ICER of an HIV/AIDS intervention in one context expressed 
as percentage of the ICER of that intervention in another context, is to 100%.  The last row of Table 5 shows that the 
percentage of the ICER of an intervention in a rural context, measured from the perspective of government, relative to the 
ICER of the same intervention in an urban context varies across modeled interventions. A given intervention would be 
equally effective in a rural context and an urban context if this percentage is 100%. Since reported percentages of the 
three interventions are away from 100% to a different extent, the extent of CE of modeled interventions depends on the 
context as shown in Table 6.  
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Table 6. Comparison of the extent of cost-effectiveness across HIV/AIDS interventions in socio-economic contexts (in 
US$/outcome) 
 
Intervention  ICER  in a rural 
context  
ICER in an 
urban context 
ICER in a rural context as % 
of the ICER in an urban 
context 
PMTCT 
HAART FOR ADULTS 
HAART FOR CHILDREN  
1367
2456 
2266 
2034
1712 
2070 
54
151 
109 
 
Source: Author, based on the results of SPMS projections 
 
The results in Table 6 illustrate that the CE of HIV/AIDS interventions  has no specific trend across a rural context and an 
urban context as some HIV/AIDS interventions are more cost-effective in a rural context, while for others, the opposite is 
true. The results also, in column 4 of Table 6, show that the extent of CE is different across interventions.  
These results are subjected to sensitivity analysis. One of the key issues likely to affect the effectiveness of 
HIV/AIDS interventions in lifelong HAART therapy is a decrease in treatment adherence. As this decrease would affect 
the coverage of HIV/AIDS interventions, the paper analyses the effect of a 20% decrease in coverage (due to a possible 
decrease in adherence) on the results of the base-case comparison. The results are presented in Table 7  
 
Table 7. Effect of a decrease in coverage rate by 20%, government’s perspective. 
 
                                   Adherence drop by 20% in rural context
 
                                           Rural context
  PMTCT HAART FOR  ADULTS HAART FOR 
CHILDREN  
Base case 
Drop 20% 
ICER GP
ICER GP 
1,367
1,417 
2,456
2,512 
2,266
2,313 
                                           Urban context
Base-case 
Base-case  
ICER GP
ICER GP 
2,034
2,034 
1,712
1,712 
2,070
2,070 
                                     Adherence drop by 20%  in urban context
 
                                          Rural context 
  PMTCT HAART FRO  ADULTS HAART  FOR 
CHILDREN  
Base- case 
Base-case 
ICER GP
ICER GP 
1,367
1,367 
2,456
2,456 
2,266
2,266 
                                          Urban context
Base case 
Drop 20% 
ICER GP
ICER GP 
2,034
2,101 
1,712
1,802 
2,070
2,145 
 
Source: Source: Author, based on the results of SPMS projections. GP: government perspective costs, SP: societal 
perspective costs. 
 
A decrease in the adherence by 20% in one context does not affect the result of the base-case estimates in another 
context but only estimates in the context in which the decrease takes place. For instance, a decrease in adherence in a 
rural context by 20% does not affect the ICER of PMTCT in an urban context. The ICER of PMTCT in an urban context 
remains equal to the ICER of the base-case comparison, that is, US$ 2034.  When there is a decrease in adherence in a 
rural context by 20% however, the ICER of HIV/AIDS interventions in a rural context increases. For instance, the ICER of 
PMTCT increases from US$ 1367 to US$1417. An implication of this result is that effectiveness of modeled HIV/AIDS 
interventions decrease more than the decrease in the cost as a result of a reduction in the coverage by 20%. 
Similarly, the decrease in adherence by 20% in urban contexts does not affect the results of the base-case 
comparison in a rural context. However, this decrease in adherence increases the ICER of HIV/AIDS interventions in an 
urban context. Table 7 shows that the ICER of PMTCT in an urban context, for instance, increases from US$2,034 to 
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US$ 2,101. Again, this observation signifies that, as a result of the decrease in adherence by 20% in a given context, the 
decrease in the effectiveness is more than the decrease in the costs. However, even though the decrease in the 
adherence affects the CE of an intervention in a context in which the decrease takes place, it does not affect the 
comparability of CE of HIV/AIDS interventions across contexts. Therefore the results of the base-case comparison are 
robust to the change in the adherence.  
The discount rates used have been considered as factors influencing the cost-effectiveness results. Consequently, 
it was recommended (Gold et al., 1996) to check how the conclusions of the base-case comparison change with different 
discount rates. To this end, cost-effectiveness results of the base-case comparison were reproduced using different 
discount rates. Table 8 shows the ICER of HIV with different discount rates. The Table shows as expected, that the 
ICERs of HIV/AIDS interventions decrease as the discount rates increase. The results show for example that with a 
discount rate of 3%, the ICER of PMTCT of US$1,367 (measured from the government’s perspective) in a rural context 
changes to US$1,089 with a discount rate of 7%. The same patterns in the change of ICER are observed in an urban 
context. While these changes are observed for all modeled interventions, they do not change the base-case conclusion.  
 
Table 8. Effect of using different discount rates 
 
Discount 
rate 
 Rural context Urban context
ICER PMTCT HAART HAART FOR 
CHILDREN  
PMTCT HAART FOR 
ADULTS  
HAART FOR 
CHILDREN  
0% 
 
3% 
 
7% 
ICER GP 
ICER SP 
ICER GP 
ICER SP 
ICER GP 
ICER SP 
1,654
1,805 
1,367 
1,538 
1,089 
1,188 
2,713
2,915 
2,456 
2,086 
1,615 
1,745 
2,250
2,480 
2,266 
2,379 
1,714 
1,815 
2,219
2,311 
2,034 
2,051 
1,609 
1,723 
1,888
1,801 
1712 
1,912 
1,579 
1,562 
2,315 
2,429 
2,070 
2,149 
2,567 
1,697 
 
Source: Author, based on the results of SPMS projections. ICER is measured as costs per infection averted for PMTCT, 
per death averted for HAART interventions. GP: government perspective costs, SP: societal perspective costs  
 
Finally, the insufficiency of cost data evidence required a scenario analysis of what would happen to the base-case 
conclusions when the lower and upper bound estimates of costs were used. Table 9 shows the results.  
 
Table 9. Effect of using lower and upper bound cost estimates  
 
                                                 Lower bound estimates 
         Rural context
Intervention PMTCT HAART FOR ADULTS HAART FOR CHILDREN  
ICER GP 
ICER SP 
685
752 
632
759 
736
753 
                                                  Urban context
Intervention PMTCT HAART HAARTC
ICER GP 
ICER SP 
1,050
1,115 
803
830 
655
690 
                                              Upper  bound estimates
                                                   Rural context
Intervention PMTCT HAART FOR ADULTS HAART FOR CHILDREN  
ICER GP 
ICER SP 
2,815
2,912 
1,265
1,560 
2,150
2,250 
                                                  Urban  context
ICER/Intervention
ICER GP 
ICER SP 
PMTCT
1,850 
2,856 
HAART FOR ADULTS
1,315 
1395  
HAART FOR CHILDREN  
2,400 
2,420 
 
Source: Author, based on the results of SPMS projections. Keys: GP: government perspective costs, SP: societal perspective 
costs  
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The results in Table 9 show that the use of lower and upper bound cost estimates changes some of the conclusions in 
the base-case analysis. For instance, in the base-case comparison, PMTCT was more cost-effective in a rural context 
than it was in an urban context.  While the intervention remains more cost-effective in a rural context with the use of lower 
bound cost estimates, the opposite is true when upper bound cost estimates are used.  Table 9 shows that with upper 
bound estimates of costs, the ICER of PMTCT in a rural context becomes US$2,815 per infection averted while it is US$ 
1,850 per infection averted in an urban context. This result makes PMTCT more cost-effective in an urban context and 
this conclusion is different from the conclusion in the base-case comparison.  The change in the CE comparability of 
PMTCT across a rural context and an urban context as a result of a change in cost estimates applies to other modeled 
interventions. HAART FOR ADULTS which was more cost-effective in an urban context than in rural context becomes 
less cost-effective when lower bound cost estimates are used as shown in Table 9. As the results in the latter Table 
change many of the conclusions reached by the base-case comparison, the results are not robust to a change in 
estimates of cost.    
 
4. Discussion and conclusion  
 
4.1 Discussion    
 
This paper set out to find out whether the CE estimates of HIV/AIDS interventions changes from a rural context to an 
urban context in South Africa. Estimates obtained through modeling with Spectrum Policy Modeling System, which 
allowed the interaction between HIV/AIDS interventions and these contexts to be taken into account, revealed that the CE 
of an HIV/AIDS intervention indeed depends on the context of its implementation. Briefly, the paper found that a given 
HIV/AIDS intervention results in different CE estimates depending on whether it is implemented in a rural context or an 
urban context.  In particular, the paper found that the ICER of PMTCT in a rural context expressed as a percentage of its 
ICER in the urban context is 67%. In contrast, the ICERs of HAART FOR ADULTS and HAART FOR CHILDREN in a 
rural context are 143% and 109% of the ICERs of the same interventions in an urban context.   
Bearing in mind that the ICER of an intervention is the additional costs per additional health outcomes of an 
intervention as compared to “usual care”, the lower the ICER, the more cost-effective is the intervention. Linking this 
information to the results above, it is clear that an HIV/AIDS intervention is not equally cost-effective across socio-
economic contexts. If an intervention was equally cost-effective across contexts, its ICER in one context as a percentage 
of its ICER in another context would be 100%. The percentage was less that 100% for PMTCT, suggesting that the latter 
intervention is more cost-effective in a rural context. In contrast, since the percentage was higher for HAART for adults 
and HAART for children, the latter intervention is more cost-effective in the urban context.  
The results have shown that the extent of CE is different across interventions in socio-economic contexts. Not only 
is CE of an HIV/AIDS intervention different in socio-economic contexts, but also the extent of the difference varies across 
modeled HIV/AIDS interventions.  For instance, the results indicate that HAART for adults has the greatest extent of CE 
in the context in which it is more cost effective (the relative ICER is 143%). These results have provided ample evidence 
that the CE of HIV/AIDS interventions depends on the context, answering our research question on whether or not the CE 
of an HIV/AIDS intervention depends  on the context and if so, to what extent. The results have indicated that CE and its 
extent indeed depend on the context and on the type of HIV/AIDS intervention.  
Interpreting the meaning of these results requires reverting back to the methodology used in this analysis. After 
controlling for the difference in the sizes of patients, the costs and effectiveness results should have been the same 
across contexts. The fact that the results are not the same can be explained by the influence of the interaction between 
HIV/AIDS interventions and contextual and individual factors. Theory indicates that those individual risk behaviours can 
be shaped by the contexts in which people live (see for instance among many others, Marmot & Wilkinson, 2005; 
Phillipson and Poster, 1993; Ajzen, 1991). Since these factors prevail to a different extent and in complex patterns in 
modeled contexts, and a standard HIV/AIDS intervention does not necessarily target all these factors, the CE of an 
HIV/AIDS intervention across a rural context and an urban context is doomed to be different.  
 These results have some precedents in the literature. Veguet and Wash (2012) compared the CE of microbicides 
in South Africa and the US. The results over one year for a hypothetical population of patients showed that the cost and 
effectiveness in the US and South Africa were different. Over one year, it was estimated that the intervention prevents 
1,908 new infections in South Africa, and 21 new infections in the US. In South Africa, the saving of the intervention was 
estimated at US$6,712 per infection averted while no saving was reported in the US. A related study by Dowdy et al. 
(2006) compared the CE of nitrile female condom across South Africa and Brazil, which are comparable in in terms of 
ISSN 2039-2117 (online) 
ISSN 2039-9340 (print) 
        Mediterranean Journal of Social Sciences 
            MCSER Publishing, Rome-Italy 
Vol 4 No 3 
September 2013 
 
 599 
socio-economic status and risk behaviours. The results, over a period of three years on 1,000 hypothetical patients, were 
that expanding female condom use to 10% of the adult females would avert 604 infections at US$20,683 in Brazil, while 
in South Africa, 9,577 infections could be averted at US$985 per infection averted. While these studies constitute an 
important contribution to the literature, they aimed to inform international policy makers rather than South African ones.  
Finally, although the findings of this study appear to be significant with respect to policy making in resource 
allocation, they need to be understood in the context of the evidence used in the analysis. While scenario analysis on the 
discount rates and the coverage of interventions did not seem to reveal a change in the conclusions of the base-case 
analysis, the conclusions were very sensitive to the cost assumptions.  Given that the sources of estimates of the cost of 
the different interventions compared were inadequate, it is likely that the results might not be accurate.  This calls for 
more studies on the cost analysis of health care interventions in general and HIV/AIDS interventions in particular, if policy 
on HIV/AIDS interventions is to be founded on solid evidence. Previous studies have also pointed to this need in Africa 
(see Creese et al., 2002, for example).  
 
5. Conclusion  
 
This study used the best available evidence in South Africa to compare the cost-effectiveness of HIV/AIDS interventions 
in a rural context and in an urban context over the period 2007-2020. The analysis was conducted by means of Spectrum 
Policy Modeling System together with demographic, epidemic and intervention parameters for the urban and rural 
contexts. The conclusions of the study were that the cost-effectiveness of HIV/AIDS interventions depended on the socio-
economic context of intervention. While it was not possible to determine the factors underlying difference in cost-
effectiveness across rural and urban contexts, the study found it important for policy makers to start considering 
allocations of resources in HIV/AIDS interventions on the basis of cost-effectiveness evidence of such interventions in 
these contexts. For such a policy drive to be successful, more cost analysis studies are needed.   
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